Covid-19: UK restricts parallel export of nearly 200 drugs, threatening its biopharma industry

13 May 2020 (Last Updated May 13th, 2020 14:37)

The UK government has banned almost 200 drugs from parallel export in expectation of deficits caused by the Covid-19 pandemic. However, an industry group has criticised the measures, stating they undermine the supply chain.

The UK’s list of drugs banned from parallel export has increased dramatically in the past two months along with the severity of the pandemic in the country. As of the beginning of this month, the list includes 196 drugs. The GlobalData Covid-19 dashboard Country Comparison shows the UK is on a path to pass Spain for the highest number of combined confirmed Covid-19 infections. Read more here.